PharmiWeb.com - Global Pharma News & Resources
25-Jun-2019

Anticoagulants Market Size is Projected to Jump USD 39 Billion by 2026

The Global Anticoagulants Market Size is expected to reach USD 39 Billion by 2026 and growing CAGR around 7.9 % during the forecast period.

The Global Anticoagulants Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/1201

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Anticoagulants Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Anticoagulants Market?
  • What is the market drivers, restrains, opportunities governing the global Anticoagulants Market?
  • Which is the largest and the fastest growing segments in the global Anticoagulants Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Anticoagulants Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are Bristol-Myers Squibb Company, Pfizer, Inc., Bayer Healthcare, Sanofi, Boehringer Ingelheim International GmbH, Johnson amp; Johnson Services, Inc., and Daiichi Sankyo Company Limited.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1201

The Major Market Segments of GlobalAnticoagulants Marketare as below:

Market Segmentation

Market By Route of Administration

  • Oral
  • Injectable

Market By Drug Class

  • Factor XA Inhibitors (NOAC/DOAC)
  • Heparins
  • Direct Thrombin Inhibitors
  • Vitamin K Antagonists

Market By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market By Indication

  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Atrial Fibrillation
  • Heart Attack

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

In terms of consumption of anticoagulants, the North America was the dominant region in the year 2018 and the similar trend is expected to continue over forecast period due to rapid increase in the surgeries such as hip and knee surgeries in this region. Europe region is following the North America in terms of demand for anticoagulants. Increase in geriatric population is expected to be one of the key factor boosting the demand for anticoagulant in this region.

On the other hand, APAC region is expected to register significant CAGR growth rate over forecast period. The increasing health issues due to changing lifestyle as well as increasing surgical operations in this region are some of the prime factors accelerating the demand for anticoagulants in this region. Also, increasing network of healthcare facilities is expected to be another factor creating a demand for anticoagulants.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Anticoagulants
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Anticoagulants Market By Route of Administration
1.2.2.1. Global Anticoagulants Market Revenue and Growth Rate Comparison By Route of Administration (2015-2026)
1.2.2.2. Global Anticoagulants Market Revenue Share By Route of Administration in 2017
1.2.2.3. Oral
1.2.2.4. Injectable
1.2.3. Anticoagulants Market By Drug Class
1.2.3.1. Global Anticoagulants Market Revenue and Growth Rate Comparison By Drug Class (2015-2026)
1.2.3.2. Global Anticoagulants Market Revenue Share By Drug Class in 2017
1.2.3.3. Factor XA Inhibitors (NOAC/DOAC)
1.2.3.4. Heparins
1.2.3.5. Direct Thrombin Inhibitors
1.2.3.6. Vitamin K Antagonists
1.2.4. Anticoagulants Market By Distribution Channel
1.2.4.1. Global Anticoagulants Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.4.2. Global Anticoagulants Market Revenue Share By Distribution Channel in 2017
1.2.4.3. Hospital Pharmacies
1.2.4.4. Retail Pharmacies
1.2.4.5. Online Pharmacies
1.2.5. Anticoagulants Market By Indication
1.2.5.1. Global Anticoagulants Market Revenue and Growth Rate Comparison By Indication (2015-2026)
1.2.5.2. Global Anticoagulants Market Revenue Share By Indication in 2017
1.2.5.3. Deep Vein Thrombosis (DVT)
1.2.5.4. Pulmonary Embolism (PE)
1.2.5.5. Atrial Fibrillation
1.2.5.6. Heart Attack
1.2.6. Anticoagulants Market by Geography
1.2.6.1. Global Anticoagulants Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Anticoagulants Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe Anticoagulants Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific Anticoagulants Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America Anticoagulants Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) Anticoagulants Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Anticoagulants Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Anticoagulants Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Anticoagulants Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Anticoagulants Major Manufacturers in 2017

CHAPTER 4. ANTICOAGULANTS MARKET BY ROUTE OF ADMINISTRATION

4.1. Global Anticoagulants Revenue By Route of Administration
4.2. Oral
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Injectable
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ANTICOAGULANTS MARKET BY DRUG CLASS

5.1. Global Anticoagulants Revenue By Drug Class
5.2. Factor XA Inhibitors (NOAC/DOAC)
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Heparins
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Direct Thrombin Inhibitors
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Vitamin K Antagonists
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ANTICOAGULANTS MARKET BY DISTRIBUTION CHANNEL

6.1. Global Anticoagulants Revenue By Distribution Channel
6.2. Hospital Pharmacies
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Retail Pharmacies
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Online Pharmacies
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. ANTICOAGULANTS MARKET BY INDICATION

7.1. Global Anticoagulants Revenue By Indication
7.2. Deep Vein Thrombosis (DVT)
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Pulmonary Embolism (PE)
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Atrial Fibrillation
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Heart Attack
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. NORTH AMERICA ANTICOAGULANTS MARKET BY COUNTRY

8.1. North America Anticoagulants Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Anticoagulants Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. U.S.
8.3.1. U.S. Anticoagulants Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.5.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 9. EUROPE ANTICOAGULANTS MARKET BY COUNTRY

9.1. Europe Anticoagulants Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Anticoagulants Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC ANTICOAGULANTS MARKET BY COUNTRY

10.1. Asia-Pacific Anticoagulants Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Anticoagulants Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 11. LATIN AMERICA ANTICOAGULANTS MARKET BY COUNTRY

11.1. Latin America Anticoagulants Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Anticoagulants Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million
11.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million))
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 12. MIDDLE EAST ANTICOAGULANTS MARKET BY COUNTRY

12.1. Middle East Anticoagulants Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East Anticoagulants Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 13. AFRICA ANTICOAGULANTS MARKET BY COUNTRY

13.1. Africa Anticoagulants Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa Anticoagulants Market Revenue Share Comparison, 2015 amp; 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
13.3.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
13.3.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
13.4.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
13.4.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
13.5.3. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
13.5.4. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE

14.1. Bristol-Myers Squibb Company
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Pfizer, Inc.
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Bayer Healthcare
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. Sanofi
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Boehringer Ingelheim International GmbH
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Johnson amp; Johnson Services, Inc.
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Daiichi Sankyo Company Limited
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies

CHAPTER 15. RESEARCH APPROACH

15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1201

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 25-Jun-2019